How the CircaVent project aims to destigmatize mental health and advance brain research
Sesame, salt, and substance. A flagship bake.
Summary
An interview with Matthew Woodworth about the CircaVent project at the Wyss Institute, which aims to destigmatize mental health issues and democratize brain-related research. The article discusses how stigma around mental illness prevents many from seeking treatment, and how CircaVent's work on understanding conditions like bipolar disorder could improve treatment approaches and public understanding.
Key quotes
· 3 pulledMore than one in five U.S. adults experience mental illness each year, but in 2024, only 52.1% of them received treatment.
One reason people are reluctant to seek help is because of the stigma surrounding mental health.
Often, that stigma comes from a lack of understanding and fear.
You might also wanna read
2026 Regeneron ISEF finalists apply biochemistry and AI to address the mental health crisis
This article highlights how 2026 Regeneron ISEF finalists are using biochemistry, AI, and medical research to develop solutions for the ment
societyforscience.org·4d ago
A Framework for Implementing Family-Focused Mental Health Care
This Viewpoint article outlines a framework for implementing family-focused mental health care, emphasizing the need to address mental healt
doi.org·4d ago
Study Shows Youth Suicide Rates Declined After 988 National Hotline Implementation
A new study found that youth suicide rates in the United States dropped 11% below projections in the two and a half years following the 2022
nytimes.com·1mo ago
ESA Research Examines Health Risks of Toxic Lunar Dust for Future Moon Missions
The article discusses the toxic effects of lunar dust on human health, based on Apollo astronauts' experiences where Moon dust caused throat
Major Lancet Review Finds Medicinal Cannabis Ineffective for Anxiety, Depression, and PTSD
A major systematic review published in The Lancet finds that medicinal cannabis does not effectively treat anxiety, depression, or PTSD, des
Pharmaceutical LSD (MM120) Shows Promise in Treating Generalized Anxiety Disorder in UCSF Clinical Trials
Researchers at UCSF are testing MM120, a pharmaceutical form of LSD, as a treatment for generalized anxiety disorder (GAD). The treatment ha